Sortera Bio woos antibody discovery specialist as Chair
Sortera Bio in Cambridge has wooed one of the all-time big guns of antibody discovery as its new Board chair. Dr David Llewellyn has literally leapt aboard to lead the company – which he describes as revolutionary, through its next phase of growth. Dr Llewellyn replaces Robert Tansley, who is stepping down as Executive Chair and will remain on the board as an investor director.